Travere Therapeutics Inc.

NASDAQ: TVTX · Real-Time Price · USD
18.76
0.53 (2.91%)
At close: Aug 15, 2025, 12:49 PM

Travere Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
58.53M 58.18M 61.69M 165.75M
Short-Term Investments
312.17M 508.68M 388.56M 387.13M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
53.82M 42.16M 11.06M 11.07M
Receivables
27.12M 21.18M 16.65M 15.91M
Inventory
6.2M 9.41M 6.92M 7.31M
Other Current Assets
12.69M 19.34M 15.02M 247K
Total Current Assets
416.7M 616.77M 486.44M 582.83M
Property-Plant & Equipment
19.63M 25.54M 30.05M 34.3M
Goodwill & Intangibles
103.97M 104.44M 145.04M 148.44M
Total Long-Term Assets
177.42M 172.14M 186.15M 193.81M
Total Assets
594.13M 788.91M 672.59M 776.63M
Account Payables
23.53M 41.67M 17.29M 15.14M
Deferred Revenue
2.81M 7.1M 11.98M 16.27M
Short-Term Debt
68.68M n/a 4.43M 3.91M
Other Current Liabilities
100.32M 94.32M 68.76M 58.86M
Total Current Liabilities
200.75M 177.91M 142.16M 124.09M
Long-Term Debt
310.31M 377.26M 403.06M 226.58M
Other Long-Term Liabilities
23.99M 8.48M 46.08M 71.98M
Total Long-Term Liabilities
334.3M 410.19M 487.57M 350.43M
Total Liabilities
535.05M 588.1M 629.73M 474.52M
Total Debt
401.58M 404.78M 407.49M 261.99M
Common Stock
9K 7K 6K 6K
Retained Earnings
-1.45B -1.13B -1.01B -765.97M
Comprehensive Income
-80K -1.46M -2.91M -562K
Shareholders Equity
59.08M 200.81M 42.85M 302.11M
Total Investments
312.17M 508.68M 388.56M 387.13M